NCORP Pilot Grant – Call for Letter of Intent (LOI)
NRG NCORP is soliciting LOIs in preparation for the next NCORP pilot grant RFA.
- Anyone interested in applying must submit a Letter of Intent (LOI) by October 11, 2024. Click here to download the form.
- The request for funding application (RFA) for NCORP pilot projects will be released in Spring 2025; however, interested applicants must submit a LOI.
- NCORP committee chairs will review LOIs and select those best aligned with committee goals, NCORP priorities and feasible.
- Selected investigators will be notified and invited to attend a workshop the NRG Winter Meeting in Phoenix, Arizona; January 16-18, 2025.
Informational slides are available here.
Webinar: NCORP Neurocognitive Workshop
View the flyer.
Webinar: Developing and Running an R01 Through NRG Oncology NCORP
Watch the recording Passcode: *?7c+Guh
View the slides
NRG NCORP Overview
NRG Oncology received a five-year funding award in fall 2014 to carry out clinical research as a National Cancer Institute (NCI) Community Oncology Research Program (NCORP) Research Base. The NRG NCORP Research Base will provide scientific and statistical leadership for developing, implementing, and analyzing multi-institutional clinical trials of cancer prevention, control, screening, and post treatment surveillance, as well as cancer care delivery research (CCDR).
NRG NCORP research plans are well integrated into NRG Oncology’s scientific program, which includes a unique focus on both women’s health and radiation therapy. The overarching research themes the NRG NCORP plans to pursue include:
- Developing and evaluate interventions designed to prevent or reduce the risk of cancer as well as cancer treatment morbidities, and improve QoL and overall outcomes.
- Testing and further validating patient-reported measures across many cancer disease types to evaluate and design interventions to improve the quality of life of cancer survivors.
- Develop and conduct randomized and pragmatic implementation trials of interventions that have the potential to generate benefits comparable to those found in drug treatment trials.
- Leveraging NRG Oncology’s therapeutic trials to provide a unique research portfolio—with particular foci on women’s cancers and radiation oncology innovation—to NRG Oncology’s research community and across the National Clinical Trials Network (NCTN).
- Understand and address health disparities in an effort to reduce the unequal burden of cancer in the US.
Learn More About Opportunities and Working with NRG NCORP
The First Lady of the United States and NCI Leadership Highlight the Importance of NCORP on World Cancer Day
